Resources

Share this article

Mepilex® Ag in the management of partial-thickness burns: A review of the clinical evidence

Phil Davies, Ulana Pawlak
15 March 2022

Burn injuries are the result of direct contact with fire/flame, hot liquids/surfaces, and electrical sources that cause cellular damage to the skin, and chemical agents that damage skin structures (Toussaint and Singer, 2014).

​Even as emergency management improves, burns continue to cause significant morbidity and mortality (Warby and Maani, 2019); globally, an estimated 180,000 deaths are caused annually by burns, which occur mainly in the home and workplace (World Health Organisation [WHO], 2018). In 2008, over 410,000 burn injuries were recorded in the United States of America, with approximately 40,000 of the victims requiring hospitalisation (WHO, 2018). In the United Kingdom, there are approximately 13,000 hospitalised burn casualties and 300 deaths annually, with a mortality rate of 2.31% (Page et al, 2017). Additionally, it is estimated that over 10 million individuals suffer from burns every year in China (Zheng et al, 2019).

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.